Brand dynamics

Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health

Calling for Social Attention to Early Diagnosis and Treatment of COPD—The "Shutanlin® Early COPD Treatment Project" Launch Meeting Successfully Held

Time Posted:2021-06-28 19:26

On the afternoon of June 22, 2021, an online launch meeting was held for a nationwide multicenter clinical study, "Compound ipratropium bromide (Shutanlin®) treatment of early COPD project," initiated by the First Affiliated Hospital of Guangzhou Medical University/Guangzhou Institute of Respiratory Health/National Center for Respiratory Medicine/National Clinical Research Center for Respiratory Diseases.

Three major varieties of Jiankangyuan inhalation preparations won bids in the fifth batch of centralized procurement, benefiting more respiratory patients

Time Posted:2021-06-24 17:18

On June 23, the fifth round of national drug centralized procurement bidding was opened. Three inhaled preparations from Health Yuan - Budesonide Suspension for Inhalation (2ml:1mg), Compound Ipratropium Bromide Solution for Inhalation (Shutanlin), and Ipratropium Bromide Solution for Inhalation (Liwu'an) - all won bids!

Major Technological Breakthrough! Health Yuan's Adibromide Inhalation Powder is Approved for Clinical Trials

Time Posted:2021-06-21 19:29

Since the development of the pharmaceutical manufacturing industry, people have paid close attention to the drug treatment of asthma, while chronic obstructive pulmonary disease (COPD) is quietly spreading among the population. It is predicted that with the increase in smoking prevalence and population aging in various countries, the prevalence of COPD will increase in the next 30 years.

Based on patient needs, Health Yuan's sodium omeprazole for injection has passed the consistency evaluation.

Time Posted:2021-06-18 20:21

Recently, Lizhu Pharmaceutical Factory (hereinafter referred to as "Lizhu Pharmaceutical Factory"), a subsidiary of the Group, received the "Approval Notice for Drug Supplement Application" issued by the National Medical Products Administration. The sodium omeprazole injection produced by Lizhu Pharmaceutical Factory has passed the consistency evaluation of quality and efficacy of generic drugs.

Health Yuan contributes to rural revitalization and wins two awards at the 2021 China Brand Influence Evaluation Results Release

Time Posted:2021-06-08 14:15

Recently, the "2021 (8th) China Brand Influence Evaluation Results Release Event" was held in Beijing. This event was jointly organized by China Enterprise News Group, the Special Publication Department of Consumer Daily, the Discovery Brand column group, the Brand Power · Autonomous Brand Selection Demonstration Project of the People's Daily Market News online edition, the China International Brand Strategy Research Center of the University of International Business and Economics, and the Beijing Brand Association.

We are the sea of flowers in May, embracing the times with our youth

Time Posted:2021-06-08 10:16

To put the corporate culture values of "Happy Life, Happy Work" into practice, while paying attention to the steady progress of the group's various work, the Corporate Culture Department has opened the "Employee Micro-Perspective" column to showcase everyone's work and life status. We welcome everyone to provide materials, and let's work together to add fuel to our work and color to our lives.

< 1...272829...50 >